CN1233176A - 取代的三环化合物 - Google Patents

取代的三环化合物 Download PDF

Info

Publication number
CN1233176A
CN1233176A CN97198834A CN97198834A CN1233176A CN 1233176 A CN1233176 A CN 1233176A CN 97198834 A CN97198834 A CN 97198834A CN 97198834 A CN97198834 A CN 97198834A CN 1233176 A CN1233176 A CN 1233176A
Authority
CN
China
Prior art keywords
arthritis
phenyl
disease
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97198834A
Other languages
English (en)
Chinese (zh)
Inventor
N·J·巴奇
R·D·迪尔拉德
S·E·德拉黑姆
小J·M·莫林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1233176A publication Critical patent/CN1233176A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Fats And Perfumes (AREA)
CN97198834A 1996-10-30 1997-10-23 取代的三环化合物 Pending CN1233176A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2984996P 1996-10-30 1996-10-30
US60/029,849 1996-10-30

Publications (1)

Publication Number Publication Date
CN1233176A true CN1233176A (zh) 1999-10-27

Family

ID=21851210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97198834A Pending CN1233176A (zh) 1996-10-30 1997-10-23 取代的三环化合物

Country Status (26)

Country Link
EP (1) EP0839806B1 (enExample)
JP (1) JP2001503055A (enExample)
KR (1) KR20000049210A (enExample)
CN (1) CN1233176A (enExample)
AR (1) AR010050A1 (enExample)
AT (1) ATE244703T1 (enExample)
AU (1) AU734096B2 (enExample)
BR (1) BR9713261A (enExample)
CA (1) CA2269203A1 (enExample)
CO (1) CO4920250A1 (enExample)
CZ (1) CZ136899A3 (enExample)
DE (1) DE69723393T2 (enExample)
DK (1) DK0839806T3 (enExample)
EA (1) EA003992B1 (enExample)
ES (1) ES2202560T3 (enExample)
ID (1) ID18685A (enExample)
IL (1) IL129481A0 (enExample)
NO (1) NO314899B1 (enExample)
NZ (1) NZ335246A (enExample)
PE (1) PE10999A1 (enExample)
PL (1) PL332896A1 (enExample)
PT (1) PT839806E (enExample)
TR (1) TR199900956T2 (enExample)
TW (1) TW513428B (enExample)
WO (1) WO1998018464A1 (enExample)
YU (1) YU19299A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112409493A (zh) * 2020-08-12 2021-02-26 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
HUP0102981A3 (en) 1998-03-31 2002-10-28 Shionogi & Co Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof
IL129484A0 (en) * 1998-04-17 2000-02-29 Lilly Co Eli Substituted tricyclics
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
TR200003194T2 (tr) 1998-05-01 2001-03-21 Eli Lilly And Company Hastalık tedavisine mahsus sPLA2 önleyici bileşikler
KR20010034881A (ko) 1998-05-21 2001-04-25 시오노 요시히코 ｓＰＬＡ2 억제 효과를 갖는 피롤로[1,2-ｂ]피리다진 유도체
ATE329619T1 (de) 1998-10-14 2006-07-15 Shionogi & Co Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
US6448284B1 (en) * 1998-12-22 2002-09-10 Eli Lilly And Company Substituted tricyclics
AU6015600A (en) 1999-07-19 2001-02-05 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
US6673781B1 (en) 1999-08-02 2004-01-06 Shionogi & Co., Ltd. Tricyclic compounds having sPLA2-inhibitory activities
US6787545B1 (en) 1999-08-23 2004-09-07 Shiongi & Co., Ltd. Pyrrolotriazine derivatives having spla2-inhibitory activities
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
US6756376B1 (en) 1999-11-15 2004-06-29 Shionogi & Co., Ltd. Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities
WO2001049323A1 (en) * 2000-01-06 2001-07-12 Eli Lilly And Company Combination therapy for the treatment of inflammatory and respiratory diseases
JPWO2002000621A1 (ja) 2000-06-29 2004-04-22 塩野義製薬株式会社 Ｘ型ｓＰＬＡ２阻害作用を有する化合物
WO2002000256A1 (fr) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedes contre la cirrhose
US6872743B2 (en) 2000-12-18 2005-03-29 Eli Lilly And Company sPLA2 inhibitors
TWI314457B (enExample) 2001-03-19 2009-09-11 Shionogi & Co
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US8329913B2 (en) 2004-10-29 2012-12-11 Zeria Pharmaceutical Co., Ltd. Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
ES2924728T3 (es) 2015-06-15 2022-10-10 Raziel Therapeutics Ltd Derivados de carbazol para el tratamiento de enfermedades fibróticas, así como de síntomas y afecciones relacionados con las mismas
US12440370B2 (en) 2020-10-21 2025-10-14 Purewick Corporation Apparatus with compressible casing for receiving discharged urine
US12208031B2 (en) 2020-10-21 2025-01-28 Purewick Corporation Adapters for fluid collection devices
US12257174B2 (en) 2020-10-21 2025-03-25 Purewick Corporation Fluid collection assemblies including at least one of a protrusion or at least one expandable material

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479391A (en) * 1966-10-03 1969-11-18 Squibb & Sons Inc Delta**3,14-17alpha-hydroxy-norprogesterone and esters
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112409493A (zh) * 2020-08-12 2021-02-26 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用
CN112409493B (zh) * 2020-08-12 2022-09-30 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用

Also Published As

Publication number Publication date
PT839806E (pt) 2003-11-28
NO991831L (no) 1999-06-21
PE10999A1 (es) 1999-02-10
DE69723393T2 (de) 2004-06-09
ES2202560T3 (es) 2004-04-01
EP0839806B1 (en) 2003-07-09
KR20000049210A (ko) 2000-07-25
EA199900305A1 (ru) 1999-12-29
NO991831D0 (no) 1999-04-16
NZ335246A (en) 2001-09-28
ATE244703T1 (de) 2003-07-15
CO4920250A1 (es) 2000-05-29
AR010050A1 (es) 2000-05-17
NO314899B1 (no) 2003-06-10
TR199900956T2 (xx) 1999-07-21
DK0839806T3 (da) 2003-10-27
CA2269203A1 (en) 1998-05-07
AU5149498A (en) 1998-05-22
EP0839806A1 (en) 1998-05-06
EA003992B1 (ru) 2003-12-25
BR9713261A (pt) 2000-03-28
YU19299A (sh) 2000-03-21
WO1998018464A1 (en) 1998-05-07
TW513428B (en) 2002-12-11
IL129481A0 (en) 2000-02-29
ID18685A (id) 1998-04-30
JP2001503055A (ja) 2001-03-06
PL332896A1 (en) 1999-10-25
AU734096B2 (en) 2001-06-07
CZ136899A3 (cs) 1999-09-15
DE69723393D1 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
CN1149193C (zh) 取代的三环化合物
CN1068588C (zh) 磷脂酶a2抑制剂1h－吲哚－3－乙酰胺类化合物
CN1067054C (zh) 1H-吲哚-3-乙醛酰胺sPLA2抑制剂
CN1067986C (zh) 1h－吲哚－3－乙酰肼磷脂酶a2抑制剂
CN1055089C (zh) 蛋白激酶c抑制剂的中间体及其制法
CN1124262C (zh) 用作内皮缩血管肽受体拮抗剂的吲哚衍生物
CN1193018C (zh) 杂环衍生物及其医药用途
CN1032203C (zh) 制备取代2-吡啶酮和吡啶-2-硫酮的方法
CN1041941A (zh) 苯并二氮杂衍生物的制备方法
CN1085556A (zh) 抗偏头痛的吲哚-3-基烷基哌嗪的4-嘧啶基和吡啶基衍生物
CN1549814A (zh) 作为1型纤溶酶原激活物抑制剂(pai-1)的抑制剂的取代萘基吲哚衍生物
CN1133040A (zh) 作为雌激素激动剂的苯并噻吩及其有关化合物
CN1158121A (zh) 吲哚嗪sPLA2抑制剂
CN1059717A (zh) 5-羟色胺兴奋剂
CN1268133A (zh) 含有稠合环取代基的作为nos抑制剂的2－氨基吡啶
CN1210521A (zh) 异喹啉衍生物及医药
CN1085897A (zh) 血管紧张肽ii拮抗剂
CN1066065A (zh) 杂环取代的苯乙酸衍生物及其制法和药物用途
CN1060841A (zh) 喹唑啉衍生物及其制备方法
CN1119856A (zh) Hiv逆转录酶抑制剂
CN1111622A (zh) 丙烯酸衍生物
CN1531537A (zh) 用作保胎催产素受体拮抗剂的新型三环吡啶基苯并氮杂�羧酰胺及其衍生物
CN1079222A (zh) 含喹啉和喹唑啉衍生物的药用组合物及其新化合物
CN1235968A (zh) 取代的三环化合物
CN1639121A (zh) 具有鸦片样受体亲合性的3－氮杂二环并(3.1.0)己烷衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication